Delivery Order SPE2DB22D3501-SPE2DB23FWV84
Award Date 8/14/23
Potential Completion Date 8/15/23
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 23, 2023. Emgality is a medication used to treat conditions such as migraine and cluster headache. The Defense Logistics Agency leverages contracts such as this to efficiently procure pharmaceuticals and other medical supplies for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $834 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in August 2023. Emgality is used to treat conditions such as migraine and cluster headache. This order was issued under an existing DLA contract vehicle but details of the vehicle were not provided....
- The Defense Logistics Agency awarded a $2,555.11 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 MG/ML Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by June 27, 2023 in support of the Defense Logistics Agency's medical supply needs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. No set aside designation or subcontractors were identified. The...
- The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to provide the medication to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors were indicated. This order was issued under an existing DLA medical supply vehicle to fulfill requirements...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $139,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for 120 mg/ml Emgality pens and will be performed in Conshohocken, Pennsylvania between July 26-27, 2023. Emgality is likely being procured to treat conditions such as migraine and cluster headaches for DOD personnel as part of the Agency's medical supply chain responsibilities. No set...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 MG/ML Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023. Emgality is a medication used to prevent migraine headaches. This delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract, which establishes Amerisourcebergen as a primary supplier of prescription...
- The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the medication to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA pharmaceutical supply vehicle to fulfill...
- The Defense Logistics Agency awarded a $139,090 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the requested pharmaceutical products to DLA from September 15-18, 2023. Amerisourcebergen will deliver Emgality pens from its facility in Conshohocken, Pennsylvania to an unknown customer or customers of the Defense Logistics Agency. No...
- The Defense Logistics Agency awarded a $2,289.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 22, 2023 under the terms of the order. Emgality is a monoclonal antibody used to treat migraine headaches. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 29, 2023 under the terms of the order. Emgality is likely being procured to support DLA's mission to provide medical supplies and equipment to the U.S. military worldwide. No set aside designation...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWV84Delivery Order
The Defense Logistics Agency awarded a $2,065.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 15, 2023 in support of DLA programs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. Amerisourcebergen will deliver the requested pharmaceutical products as the prime contractor, with no subcontractors mentioned. The funding comes from DLA's medical supply chain responsibilities for the Department of Defense.
Generated 12/22/23, 9:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/14/23 |